Cargando…

Adult cognitive outcomes in phenylketonuria: explaining causes of variability beyond average Phe levels

OBJECTIVE: The objective was to deepen the understanding of the causes of individual variability in phenylketonuria (PKU) by investigating which metabolic variables are most important for predicting cognitive outcomes (Phe average vs Phe variation) and by assessing the risk of cognitive impairment a...

Descripción completa

Detalles Bibliográficos
Autores principales: Romani, Cristina, Manti, Filippo, Nardecchia, Francesca, Valentini, Federica, Fallarino, Nicoletta, Carducci, Claudia, De Leo, Sabrina, MacDonald, Anita, Palermo, Liana, Leuzzi, Vincenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6883518/
https://www.ncbi.nlm.nih.gov/pubmed/31779649
http://dx.doi.org/10.1186/s13023-019-1225-z
_version_ 1783474390856368128
author Romani, Cristina
Manti, Filippo
Nardecchia, Francesca
Valentini, Federica
Fallarino, Nicoletta
Carducci, Claudia
De Leo, Sabrina
MacDonald, Anita
Palermo, Liana
Leuzzi, Vincenzo
author_facet Romani, Cristina
Manti, Filippo
Nardecchia, Francesca
Valentini, Federica
Fallarino, Nicoletta
Carducci, Claudia
De Leo, Sabrina
MacDonald, Anita
Palermo, Liana
Leuzzi, Vincenzo
author_sort Romani, Cristina
collection PubMed
description OBJECTIVE: The objective was to deepen the understanding of the causes of individual variability in phenylketonuria (PKU) by investigating which metabolic variables are most important for predicting cognitive outcomes (Phe average vs Phe variation) and by assessing the risk of cognitive impairment associated with adopting a more relaxed approach to the diet than is currently recommended. METHOD: We analysed associations between metabolic and cognitive measures in a mixed sample of English and Italian early-treated adults with PKU (N = 56). Metabolic measures were collected through childhood, adolescence and adulthood; cognitive measures were collected in adulthood. Metabolic measures included average Phe levels (average of median values for each year in a given period) and average Phe variations (average yearly standard deviations). Cognition was measured with IQ and a battery of cognitive tasks. RESULTS: Phe variation was as important, if not more important, than Phe average in predicting adult outcomes and contributed independently. Phe variation was particularly detrimental in childhood. Together, childhood Phe variation and adult Phe average predicted around 40% of the variation in cognitive scores. Poor cognitive scores (> 1 SD from controls) occurred almost exclusively in individuals with poor metabolic control and the risk of poor scores was about 30% higher in individuals with Phe values exceeding recommended thresholds. CONCLUSIONS: Our results provide support for current European guidelines (average Phe value = < 360 μmol/l in childhood; = < 600 μmo/l from 12 years onwards), but they suggest an additional recommendation to maintain stable levels (possibly Phe SD = < 180 μmol/l throughout life). PUBLIC SIGNIFICANCE STATEMENTS: We investigated the relationship between how well people with phenylketonuria control blood Phe throughout their life and their ability to carry out cognitive tasks in adulthood. We found that avoiding blood Phe peaks was as important if not more important that maintaining average low Phe levels. This was particularly essential in childhood. We also found that blood Phe levels above recommended European guidelines was associated with around 30% increase in the risk of poor cognitive outcomes.
format Online
Article
Text
id pubmed-6883518
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-68835182019-12-03 Adult cognitive outcomes in phenylketonuria: explaining causes of variability beyond average Phe levels Romani, Cristina Manti, Filippo Nardecchia, Francesca Valentini, Federica Fallarino, Nicoletta Carducci, Claudia De Leo, Sabrina MacDonald, Anita Palermo, Liana Leuzzi, Vincenzo Orphanet J Rare Dis Research OBJECTIVE: The objective was to deepen the understanding of the causes of individual variability in phenylketonuria (PKU) by investigating which metabolic variables are most important for predicting cognitive outcomes (Phe average vs Phe variation) and by assessing the risk of cognitive impairment associated with adopting a more relaxed approach to the diet than is currently recommended. METHOD: We analysed associations between metabolic and cognitive measures in a mixed sample of English and Italian early-treated adults with PKU (N = 56). Metabolic measures were collected through childhood, adolescence and adulthood; cognitive measures were collected in adulthood. Metabolic measures included average Phe levels (average of median values for each year in a given period) and average Phe variations (average yearly standard deviations). Cognition was measured with IQ and a battery of cognitive tasks. RESULTS: Phe variation was as important, if not more important, than Phe average in predicting adult outcomes and contributed independently. Phe variation was particularly detrimental in childhood. Together, childhood Phe variation and adult Phe average predicted around 40% of the variation in cognitive scores. Poor cognitive scores (> 1 SD from controls) occurred almost exclusively in individuals with poor metabolic control and the risk of poor scores was about 30% higher in individuals with Phe values exceeding recommended thresholds. CONCLUSIONS: Our results provide support for current European guidelines (average Phe value = < 360 μmol/l in childhood; = < 600 μmo/l from 12 years onwards), but they suggest an additional recommendation to maintain stable levels (possibly Phe SD = < 180 μmol/l throughout life). PUBLIC SIGNIFICANCE STATEMENTS: We investigated the relationship between how well people with phenylketonuria control blood Phe throughout their life and their ability to carry out cognitive tasks in adulthood. We found that avoiding blood Phe peaks was as important if not more important that maintaining average low Phe levels. This was particularly essential in childhood. We also found that blood Phe levels above recommended European guidelines was associated with around 30% increase in the risk of poor cognitive outcomes. BioMed Central 2019-11-28 /pmc/articles/PMC6883518/ /pubmed/31779649 http://dx.doi.org/10.1186/s13023-019-1225-z Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Romani, Cristina
Manti, Filippo
Nardecchia, Francesca
Valentini, Federica
Fallarino, Nicoletta
Carducci, Claudia
De Leo, Sabrina
MacDonald, Anita
Palermo, Liana
Leuzzi, Vincenzo
Adult cognitive outcomes in phenylketonuria: explaining causes of variability beyond average Phe levels
title Adult cognitive outcomes in phenylketonuria: explaining causes of variability beyond average Phe levels
title_full Adult cognitive outcomes in phenylketonuria: explaining causes of variability beyond average Phe levels
title_fullStr Adult cognitive outcomes in phenylketonuria: explaining causes of variability beyond average Phe levels
title_full_unstemmed Adult cognitive outcomes in phenylketonuria: explaining causes of variability beyond average Phe levels
title_short Adult cognitive outcomes in phenylketonuria: explaining causes of variability beyond average Phe levels
title_sort adult cognitive outcomes in phenylketonuria: explaining causes of variability beyond average phe levels
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6883518/
https://www.ncbi.nlm.nih.gov/pubmed/31779649
http://dx.doi.org/10.1186/s13023-019-1225-z
work_keys_str_mv AT romanicristina adultcognitiveoutcomesinphenylketonuriaexplainingcausesofvariabilitybeyondaveragephelevels
AT mantifilippo adultcognitiveoutcomesinphenylketonuriaexplainingcausesofvariabilitybeyondaveragephelevels
AT nardecchiafrancesca adultcognitiveoutcomesinphenylketonuriaexplainingcausesofvariabilitybeyondaveragephelevels
AT valentinifederica adultcognitiveoutcomesinphenylketonuriaexplainingcausesofvariabilitybeyondaveragephelevels
AT fallarinonicoletta adultcognitiveoutcomesinphenylketonuriaexplainingcausesofvariabilitybeyondaveragephelevels
AT carducciclaudia adultcognitiveoutcomesinphenylketonuriaexplainingcausesofvariabilitybeyondaveragephelevels
AT deleosabrina adultcognitiveoutcomesinphenylketonuriaexplainingcausesofvariabilitybeyondaveragephelevels
AT macdonaldanita adultcognitiveoutcomesinphenylketonuriaexplainingcausesofvariabilitybeyondaveragephelevels
AT palermoliana adultcognitiveoutcomesinphenylketonuriaexplainingcausesofvariabilitybeyondaveragephelevels
AT leuzzivincenzo adultcognitiveoutcomesinphenylketonuriaexplainingcausesofvariabilitybeyondaveragephelevels